somatuline/suramin

Known as: Somatuline/SUR, Suramin/Somatuline 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2017
012319972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Medullary thyroid carcinoma (MTC) is a rare disease. Treatment options for recurrent disease are limited. Although… (More)
Is this relevant?
2011
2011
BACKGROUND Somatostatin analogues are the mainstay of therapy for malignant carcinoid syndrome. There is clear evidence that the… (More)
Is this relevant?
2011
2011
OBJECTIVE To assess the efficacy of different dosing intervals of lanreotide, Somatuline Autogel® (Lan-ATG) 120 mg in patients… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
CONTEXT Congenital hyperinsulinism (CH) may be treated conservatively in many children with octreotide given by multiple sc… (More)
Is this relevant?
Review
2002
Review
2002
Somatuline Autogel provides effective control of growth hormone levels and is at least as effective as intramuscular Somatuline… (More)
Is this relevant?
1997
1997
Octreotide, a potent synthetic somatostatin (SM) analogue, was recently evaluated and found to have a beneficial effect in… (More)
Is this relevant?